BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17327410)

  • 1. beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation.
    Meyer L; Deau B; Forejtníková H; Duménil D; Margottin-Goguet F; Lacombe C; Mayeux P; Verdier F
    Blood; 2007 Jun; 109(12):5215-22. PubMed ID: 17327410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both proteasomes and lysosomes degrade the activated erythropoietin receptor.
    Walrafen P; Verdier F; Kadri Z; Chrétien S; Lacombe C; Mayeux P
    Blood; 2005 Jan; 105(2):600-8. PubMed ID: 15358619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.
    Bulut GB; Sulahian R; Yao H; Huang LJ
    Blood; 2013 Dec; 122(24):3964-72. PubMed ID: 24113870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-TrCP mediates the signal-induced ubiquitination of IkappaBbeta.
    Wu C; Ghosh S
    J Biol Chem; 1999 Oct; 274(42):29591-4. PubMed ID: 10514424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.
    Kanemori Y; Uto K; Sagata N
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6279-84. PubMed ID: 15845771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.
    Ray D; Terao Y; Nimbalkar D; Chu LH; Donzelli M; Tsutsui T; Zou X; Ghosh AK; Varga J; Draetta GF; Kiyokawa H
    Mol Cell Biol; 2005 Apr; 25(8):3338-47. PubMed ID: 15798217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation.
    Zhang R; Huang SY; Ka-Wai Li K; Li YH; Hsu WH; Zhang GJ; Chang CJ; Yang JY
    Oncotarget; 2017 Jul; 8(30):49869-49881. PubMed ID: 28562331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the discs large tumor suppressor by a phosphorylation-dependent interaction with the beta-TrCP ubiquitin ligase receptor.
    Mantovani F; Banks L
    J Biol Chem; 2003 Oct; 278(43):42477-86. PubMed ID: 12902344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.
    Cheng Y; Gao WW; Tang HM; Deng JJ; Wong CM; Chan CP; Jin DY
    Sci Rep; 2016 Mar; 6():23938. PubMed ID: 27029215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).
    Kostopoulou E; Rojas Gil AP; Spiliotis BE
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.
    Watanabe N; Arai H; Iwasaki J; Shiina M; Ogata K; Hunter T; Osada H
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11663-8. PubMed ID: 16085715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
    Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
    Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.
    Yaron A; Hatzubai A; Davis M; Lavon I; Amit S; Manning AM; Andersen JS; Mann M; Mercurio F; Ben-Neriah Y
    Nature; 1998 Dec; 396(6711):590-4. PubMed ID: 9859996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization.
    Levin I; Cohen J; Supino-Rosin L; Yoshimura A; Watowich SS; Neumann D
    FEBS Lett; 1998 May; 427(2):164-70. PubMed ID: 9607304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.
    Klingmüller U; Lorenz U; Cantley LC; Neel BG; Lodish HF
    Cell; 1995 Mar; 80(5):729-38. PubMed ID: 7889566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase.
    Amir RE; Haecker H; Karin M; Ciechanover A
    Oncogene; 2004 Apr; 23(14):2540-7. PubMed ID: 14676825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF
    Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
    Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP.
    Spencer E; Jiang J; Chen ZJ
    Genes Dev; 1999 Feb; 13(3):284-94. PubMed ID: 9990853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.